Table 1 Characteristics of patients with diffuse large B-cell lymphoma according to SPRR1A status
Characteristics | SPRR1A− (n = 662) | SPRR1A+ (n = 305) | Pvalue |
|---|---|---|---|
Age (years) | 0.712 | ||
Median | 57 | 55 | |
Sex (%) | 0.708 | ||
Men | 483 (73) | 219 (72) | |
Women | 179 (27) | 86 (28) | |
Extranodal sites (%) | 0.203 | ||
0–1 site | 480 (73) | 209 (69) | |
More than 1 site | 182 (27) | 96 (31) | |
Performance status (%) | 0.354 | ||
0–1 | 503 (76) | 240 (79) | |
2–4 | 159 (24) | 65 (21) | |
Clinical stage (%) | 0.074 | ||
I or II | 347 (52) | 141 (46) | |
III or IV | 315 (48) | 164 (54) | |
Bulky disease >10 cm (%) | 0.858 | ||
No | 334 (51) | 152 (49) | |
Yes | 328 (49) | 153 (51) | |
IPI Score (%) | 0.218 | ||
0–1 | 342 (52) | 150 (49) | |
2 | 135 (20) | 55 (18) | |
3 | 105 (16) | 65 (21) | |
4–5 | 80 (12) | 35 (12) | |
Lactate dehydrogenase (%) | 0.757 | ||
Normal | 273 (41) | 129 (42) | |
Elevated | 389 (59) | 176 (58) | |
Evolution (%) | 0.087 | ||
CR | 418 (64) | 175 (57) | |
No CR | 244 (36) | 130 (43) |